[1] 李娜,孙汇,王拓,等.糖尿病肾病发病机制研究进展[J].北华大学学报,2012,2,13(1):68-72.
[2] 刘志红.足细胞是肾小球损伤的中心环节[N].健康报,2012-10-17(8).
[3] 戴厚永,范亚平.足细胞损伤与糖尿病肾病关系的研究进展[J].医学综述,2013,9,19(17):3173- 3175.
[4] Chen J,Gui D,Chen Y,et al.Astragaloside IV improves high glucose-induced podocyte adhesion dysfunction via pha3beta1 integrin upregulation and integrin-linked kinase inhibition[J].Biochem Pharmacol,2008,76(6):796- 804.
[5] Peter V. Hauser, Federica Collino, Benedetta Bussolati,et al. nephrin and endothelial injury[J]. Current opinion in nephrology and hypertension,2009,18(1):3- 8.
[6] SJ Shankland. The podocyte's response to injury: Role in proteinuriaand glomerulosclerosis[J]. Kidney International,2006,69(12): 2131-2147.
[7] Michael W. Steffes, Derek Schmidt, Rebecca Mccrery,et al.Glomerular cell number in normal subjects and in type 1diabetic patients[J]. Kidney International,2001,59(6):2104-2113.
[8] 匡蕾,叶山东.nephrin与糖尿病肾病的关系[J].国际病理科学与临床杂志,2011,4,31(2):140-144.
[9] William M. Deen. What determines glomerular capillary permeability[J].commentaries,2004,10(114):1412-1414.
[10] Petri Aaltonen, Pauliina Luimula, Eva Astrom,et al.Changes in the Expression of nephrin Gene and Protein in Experimental Diabetic Nephropathy[J]. Laboratory Investigation,2001, 81(9):1185-1190.
[11] 柳迎昭,吴晨光,宋丽敏,等. 糖尿病大鼠肾脏nephrin表达的动态观察[J].临床与实验病理学杂志,2010,26(6):733-737.
[12] Harry Holthofer, Heikki Ahola, Marja-Liisa Solin,et al. nephrin Localizes at the Podocyte Filtration SlitArea and Is Characteristically Spliced in theHuman Kidney[J].American Journal of Pathology,1999, 155(5): 1681-1687.
[13] 高旭光,任现国,张沛.裂孔膜蛋白nephrin和podocin与后天获得性肾脏疾病关系研究进展[J].新进展,2011,14(14):1617-1619.
[14] 李俊美.吕仁和教授治疗糖尿病肾病的经验[J].四川中医.2009,27(5):1- 3.
[15] 赵迪.高彦彬教授治疗糖尿病肾病学术思想和经验[J].中医研究,2007,20(1):42- 44.
[16] 艾志敏.芪卫颗粒干预糖尿病肾病临床和部分作用机制研究[D].北京:北京中医药大学,2013.
[17] 李敏州,高彦彬,马鸣飞,等.芪卫颗粒对KK-Ay小鼠肾组织TGF-β_1/Smads信号转导通路的影响[J].中医杂志,2013,54(13):1141-1144.
[18] 周静鑫. 芪卫颗粒干预糖尿病肾病临床疗效及其保护足细胞作用机制研究[D].北京:北京中医药大学,2014.
[19] 李步满,高彦彬,吴丽丽,等.中药芪卫颗粒对2型糖尿病大鼠肾脏氧化应激及病理改变的影响[J].中国中西医结合肾病杂志,2011,12(1):20-23.
[1]李娇阳,高彦彬,周盛楠,等.通心络对早期糖尿病肾病大鼠血管内皮生长因子表达的影响[J].环球中医药,2015,8(01):29.[doi:10.3969/j.issn.1674-1749.2015.01.008]
LI Jiao-yang,GAO Yan-bin,ZHOU Sheng-nan,et al.Effects of Tongxinluo on VEGF expression in early diabetic nephropathy rats[J].,2015,8(02):29.[doi:10.3969/j.issn.1674-1749.2015.01.008]
[2]刘迎新 邹大威 耿建国 高彦彬 尚雅文 李娇阳 龚慕辛 彭麒朕.糖肾宁对自发性2型糖尿病KK-Ay小鼠肾组织血小板衍生生长因子及受体表达的影响[J].环球中医药,2015,8(08):897.[doi: doi:10.3969/j.issn.1674-1749.2015.08.001]
LIU Ying-xin,ZOU Da-wei,GENG Jian-guo,et al.Effects of Tangshenning on PDGF, PDGFR expression of renal tissue in Type 2 diabetic KK-Ay Mice[J].,2015,8(02):897.[doi: doi:10.3969/j.issn.1674-1749.2015.08.001]
[3]仝宇 高彦彬 王晓磊 田年秀 耿建国.通心络调控p38 MAPK通路抑制细胞外基质沉积的研究[J].环球中医药,2017,10(02):146.[doi:10.3969/j.issn.1674-1749.2017.02.004]
TONG Yu,GAO Yanbin,WANG Xiaolei,et al.Research of Tongxinluo regulates and controls the expressions of p38 MAPK and extracellular matrix deposition[J].,2017,10(02):146.[doi:10.3969/j.issn.1674-1749.2017.02.004]
[4]彭麒朕 耿建国 邹大威 高彦彬 龚慕辛 吴晓明 尚雅文.糖肾宁对高糖培养的小鼠系膜细胞TGF-β1和P38MAPK表达的影响[J].环球中医药,2017,10(03):265.[doi:10.3969/j.issn.1674-1749.2017.03.003]
Peng Qizhen,Geng Jianguo,Zou Dawei,et al.Effects of Tangshenning on TGF-β1 and P38MAPK signal pathway in mouse mesangial cells with high glucose condition[J].,2017,10(02):265.[doi:10.3969/j.issn.1674-1749.2017.03.003]